Theravance Biopharma, Inc. 4 SEC Filings

Filed On	Filing
28 Sep 2026	Form 4: Weiss Asset Management Lp, Former 10% Owner and 2 others Disposed of 7,457,060 shares (Other Transaction) ($127M)
24 Sep 2026	Form 4: Miller Aine, SVP, DEV & HEAD OF IRE OFFICE Returned 189,826 shares to the issuer · Disposed of 37,500 Share Option (Right to Buy) (Disposition to Issuer)
24 Sep 2026	Form 4: Grimaud Brett A., SVP, GEN COUNSEL AND SECRETARY Returned 355,168 shares to the issuer
24 Sep 2026	Form 4: Sawaf Aziz, SVP & CHIEF FINANCIAL OFFICER Returned 336,841 shares to the issuer
24 Sep 2026	Form 4: Farnum Rhonda, SVP, COMM & MEDICAL AFFAIRS Returned 213,476 shares to the issuer · Disposed of 150,000 Share Option (Right to Buy) (Disposition to Issuer)
24 Sep 2026	Form 4: Gray Susannah, Director Returned 48,146 shares to the issuer · Disposed of 115,942 Share Option (Right to Buy) (Disposition to Issuer)
24 Sep 2026	Form 4: O'Connor Donal, Director Returned 80,213 shares to the issuer · Disposed of 135,276 Share Option (Right to Buy) (Disposition to Issuer)
24 Sep 2026	Form 4: Smaldone Alsup Laurie, Director Returned 80,989 shares to the issuer · Disposed of 148,776 Share Option (Right to Buy) (Disposition to Issuer)
24 Sep 2026	Form 4: Winningham Rick E, Director Returned 1,726,989 shares to the issuer · Disposed of 515,000 Share Option (Right to Buy) (Disposition to Issuer)
24 Sep 2026	Form 4: Pakianathan Deepika, Director Returned 64,074 shares to the issuer · Disposed of 134,276 Share Option (Right to Buy) (Disposition to Issuer)
24 Sep 2026	Form 4: Mitchell Dean J, Director Returned 97,213 shares to the issuer · Disposed of 135,276 Share Option (Right to Buy) (Disposition to Issuer)
17 Sep 2026	Form 4: Farnum Rhonda, SVP, COMM & MEDICAL AFFAIRS Sold 13,314 shares ($227K)
24 Aug 2026	Form 4: Winningham Rick E, Director Gave up 20,034 shares to cover exercise price or tax ($340K)
24 Aug 2026	Form 4: Sawaf Aziz, SVP & CHIEF FINANCIAL OFFICER Gave up 8,112 shares to cover exercise price or tax ($137K)
24 Aug 2026	Form 4: Miller Aine, SVP, DEV & HEAD OF IRE OFFICE Gave up 6,258 shares to cover exercise price or tax ($106K)
24 Aug 2026	Form 4: Grimaud Brett A., SVP, GEN COUNSEL AND SECRETARY Gave up 7,952 shares to cover exercise price or tax ($135K)
24 Aug 2026	Form 4: Farnum Rhonda, SVP, COMM & MEDICAL AFFAIRS Gave up 5,667 shares to cover exercise price or tax ($96.1K)
08 Jul 2026	Form 4: Samaha Eli, 10% owner Sold 1,400 shares ($23.9K) · Sold 5,564 shares ($95.5K)
01 Jul 2026	Form 4: Samaha Eli, 10% owner Sold 273,871 shares ($4.72M) · Sold 25,027 shares ($429K) · Sold 37,799 shares ($643K)
23 Jun 2026	Form 4: Miller Aine, SVP, DEV & HEAD OF IRE OFFICE Received 18,750 shares as a grant or award

Comments